1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with EHS Tumor in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karpatkin, S; Pearlstein, E; Salk, PL; Yogeeswaran, G | 1 |
| Handley, DA; Houlihan, WJ; Jaeggi, CS; Lee, ML; Munder, PG; Nemecek, GA; Winslow, CW | 1 |
| Harvey, W; Hopps, RM; Murphy, CT; Wasil, M | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and EHS Tumor
| Article | Year |
|---|---|
Platelet aggregating material (PAM) of two virally-transformed tumors: SV3T3 mouse fibroblast and PW20 rat renal sarcoma. Role of cell surface sialylation.
Topics: Animals; Blood Coagulation Factors; Cell Line; Cell Membrane; Cell Transformation, Viral; Cells, Cultured; Humans; Kidney Neoplasms; Mice; Neoplasm Metastasis; Platelet Activating Factor; Platelet Aggregation; Rabbits; Rats; Sarcoma, Experimental; Sialic Acids; Urea | 1982 |
Antitumor activity of a piperidine phospholipid.
Topics: Animals; Antineoplastic Agents; Binding, Competitive; Cell Survival; Fibroblasts; Fibrosarcoma; Humans; Lethal Dose 50; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Transplantation; Phospholipid Ethers; Piperidines; Platelet Activating Factor; Platelet Aggregation Inhibitors; Platelet Membrane Glycoproteins; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Receptors, Platelet-Derived Growth Factor; Sarcoma, Experimental; Tumor Cells, Cultured | 1994 |
Biosynthesis of platelet activating factor (PAF) by an osteosarcoma cell line (UMR 106).
Topics: Animals; Azepines; Cell Line; Enzyme Activation; Kinetics; Osteosarcoma; Phospholipases A; Platelet Activating Factor; Platelet Aggregation; Rats; Sarcoma, Experimental; Triazoles | 1991 |